Literature DB >> 210249

The generation and regulation of lymphocyte populations: evidence from differentiative induction systems in vitro.

M P Scheid, G Goldstein, E A Boyse.   

Abstract

Results with a dual assay, for the induction of Thy-1+ T cells and of CR+ B cells from marker-negative precursors, confirm that thymopoietin is at present the only known selective inducer of prothymocytes. In contrast, various inducers, including ubiquitin, are active in both assays. Pharmacological evidence indicates that there are different cellular receptors for ubiquitin and thymopoietin. Prothymocytes and pro-CR+ B cells compose two distinct populations in bone marrow and spleen; their distribution in density gradients is different, and elimination of either population enriches the other proportionately. There are no noteworthy differences between induction of these two populations in regard to (a) kinetics, (b) dependence on temperature and protein synthesis, (c) activation by cAMP, and (d) inhibition by cGMP. The opposite inductive effects of cAMP and cGMP were corroborated by the use of pharmacological agents that raise or lower the levels of intracellular cyclic nucleotides. In contrast, a third induction assay, which monitors acquisition of the PC+ surface phenotype, indicates that this differentiative step, the last known for B cells, is initiated by cGMP and inhibited by cAMP. Induction of PC is also inhibited by thymopoietin, signifying that the inductive selectivity of thymopoietin is not due to restriction of its receptors to the T lineage cells. Rather it seems that receptors for thymopoietin occur also on PC-inducible and other B cells, although in this case geared biochemically to inhibition rather than expression of the succeeding gene program. This suggests a role for thymopoietin in the coordinated interregulation of lymphocyte classes, in addition to its better-known function as the thymic inducer of prothymocytes. Present data conform to a general scheme in which the cyclic nucleotides cAMP and cGMP, and agents that affect intracellular levels of these mediators, influence reciprocally the early and late (functional) phases of lymphocyte differentiation as a whole, while thymopoietin influences reciprocally the differentiation of the B and T classes of lymphocyte.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 210249      PMCID: PMC2184315          DOI: 10.1084/jem.147.6.1727

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Effects of a nonapeptide FTS on lymphocyte differentiations in vitro.

Authors:  A Brand; D G Gilmour; G Goldstein
Journal:  Nature       Date:  1977-10-13       Impact factor: 49.962

2.  Thymopoietin and bursopoietin: induction signals regulating early lymphocyte differentiation.

Authors:  G Goldstein; M Scheid; E A Boyse; A Brand; D G Gilmour
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

3.  Cyclic nucleotide-dependent protein kinases. X. An assay method for the measurement of quanosine 3',5'-monophosphate in various biological materials and a study of agents regulating its levels in heart and brain.

Authors:  J F Kuo; T P Lee; P L Reyes; K G Walton; T E Donnelly; P Greengard
Journal:  J Biol Chem       Date:  1972-01-10       Impact factor: 5.157

4.  The role of cyclic 3',5' adenosine monophosphate in the specific cytolytic activity of lymphocytes.

Authors:  C S Henney; H R Bourne; L M Lichtenstein
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

5.  Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes.

Authors:  J W Hadden; E M Hadden; E Middleton
Journal:  Cell Immunol       Date:  1970-12       Impact factor: 4.868

6.  In-vitro demonstration of thymic hormone in the mouse by conversion of precursor cells into lymphocytes.

Authors:  K Komuro; E A Boyse
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

7.  Guanosine 3':5'-cyclic monophosphate: a possible intracellular mediator of mitogenic influences in lymphocytes.

Authors:  J W Hadden; E M Hadden; M K Haddox; N D Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

8.  Beta-adrenergic receptor: stereospecific interaction of iodinated beta-blocking agent with high affinity site.

Authors:  G D Aurbach; S A Fedak; C J Woodard; J S Palmer; D Hauser; F Troxler
Journal:  Science       Date:  1974-12-27       Impact factor: 47.728

9.  A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization.

Authors:  C Bianco; R Patrick; V Nussenzweig
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

10.  Receptors for complement of leukocytes.

Authors:  W H Lay; V Nussenzweig
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  35 in total

Review 1.  Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators.

Authors:  E L Ochoa; A Chattopadhyay; M G McNamee
Journal:  Cell Mol Neurobiol       Date:  1989-06       Impact factor: 5.046

Review 2.  Immunomodulation with thymopentin: in vitro studies.

Authors:  J Duchateau; K Bolla
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

3.  Thymotaxin: a thymic epithelial peptide chemotactic for T-cell precursors.

Authors:  B A Imhof; M A Deugnier; J M Girault; S Champion; C Damais; T Itoh; J P Thiery
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

4.  Arg-Lys-Asp-Val-Tyr (thymopentin) accelerates the cholinergic-induced inactivation (desensitization) of reconstituted nicotinic receptor.

Authors:  E L Ochoa; S Medrano; M C de Carlin; A M Dilonardo
Journal:  Cell Mol Neurobiol       Date:  1988-09       Impact factor: 5.046

5.  Thymopentin treatment in patients with chemotherapy-resistant lepromatous leprosy.

Authors:  A Castells; J Terencio; A Ramirez; E Sundal; K Bolla
Journal:  Surv Immunol Res       Date:  1985

6.  Expression of Thy-1 antigen is not limited to T cells in cultures of mouse hemopoietic cells.

Authors:  J W Schrader; F Battye; R Scollay
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

7.  Relation of gp70 to spontaneous cytolytic activity of mouse spleen cells.

Authors:  A Hatzfeld; A Pinter; G C Koo; E A Boyse
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

8.  The induction of immunoblastic T cell sarcomas by virus-transformed prothymocytes.

Authors:  C L Reinisch; S E Kurtz; E A Morris; A Lampert
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

9.  A general interactive model for B cell activation II. Experimental verification.

Authors:  A J Rosenspire; D M Jacobs
Journal:  Cell Biophys       Date:  1981-03

10.  Isolation and complete amino acid sequence of human thymopoietin and splenin.

Authors:  T Audhya; D H Schlesinger; G Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.